BACKGROUND: IL-32 is a proinflammatory cytokine involved in various chronic inflammatory diseases. Chronic airway inflammation in asthmatic patients results in structural airway changes, including angiogenesis. Vascular endothelial growth factor (VEGF) is a key inducer of angiogenesis in the airways of asthmatic patients. OBJECTIVE: The aim of the study was to investigate the expression and function of IL-32 in patients with angiogenesis and asthma. METHODS: The expression and regulation of IL-32 in normal human bronchial epithelial (NHBE) cells was analyzed by using RT-PCR, ELISA, Western blotting, immunofluorescent staining, and flow cytometry. After knockdown of IL-32 in NHBE cells by small interfering RNA (siRNA) transfections, VEGF secretion was quantified by means of ELISA. New blood vessel formation was determined with human umbilical vein endothelial cells by culturing with supernatants from IL-32 siRNA-transfected NHBE cells. IL-32 was determined in serum and induced sputum samples of asthmatic patients and healthy control subjects by means of ELISA. RESULTS: IL-32 is expressed in NHBE cells on stimulation with IFN-γ, TNF-α, T(H)1 cells, and rhinovirus. Inhibition of IL-32 expression resulted in significantly increased secretion of the proangiogenic factors VEGF and platelet-derived growth factor by NHBE cells. Human umbilical vein endothelial cells cultured in supernatants from IL-32 siRNA-transfected NHBE cells showed enhanced in vitro angiogenesis. IL-32 is detectable in induced sputum from asthmatic patients. IL-32 serum levels were significantly higher in asthmatic patients compared with those seen in healthy control subjects and correlated with response to asthma treatment. CONCLUSION: IL-32 is induced by IFN-γ, TNF-α, T(H)1 cells, and rhinovirus in bronchial epithelial cells. It inhibits angiogenesis, and its serum levels are associated with a good treatment response in asthmatic patients.
BACKGROUND:IL-32 is a proinflammatory cytokine involved in various chronic inflammatory diseases. Chronic airway inflammation in asthmatic patients results in structural airway changes, including angiogenesis. Vascular endothelial growth factor (VEGF) is a key inducer of angiogenesis in the airways of asthmatic patients. OBJECTIVE: The aim of the study was to investigate the expression and function of IL-32 in patients with angiogenesis and asthma. METHODS: The expression and regulation of IL-32 in normal human bronchial epithelial (NHBE) cells was analyzed by using RT-PCR, ELISA, Western blotting, immunofluorescent staining, and flow cytometry. After knockdown of IL-32 in NHBE cells by small interfering RNA (siRNA) transfections, VEGF secretion was quantified by means of ELISA. New blood vessel formation was determined with human umbilical vein endothelial cells by culturing with supernatants from IL-32 siRNA-transfected NHBE cells. IL-32 was determined in serum and induced sputum samples of asthmatic patients and healthy control subjects by means of ELISA. RESULTS:IL-32 is expressed in NHBE cells on stimulation with IFN-γ, TNF-α, T(H)1 cells, and rhinovirus. Inhibition of IL-32 expression resulted in significantly increased secretion of the proangiogenic factors VEGF and platelet-derived growth factor by NHBE cells. Human umbilical vein endothelial cells cultured in supernatants from IL-32 siRNA-transfected NHBE cells showed enhanced in vitro angiogenesis. IL-32 is detectable in induced sputum from asthmatic patients. IL-32 serum levels were significantly higher in asthmatic patients compared with those seen in healthy control subjects and correlated with response to asthma treatment. CONCLUSION:IL-32 is induced by IFN-γ, TNF-α, T(H)1 cells, and rhinovirus in bronchial epithelial cells. It inhibits angiogenesis, and its serum levels are associated with a good treatment response in asthmatic patients.
Authors: Jeong Su Park; Su Yun Choi; Jeong-Hyung Lee; Maria Lee; Eun Sook Nam; Ae Lee Jeong; Sunyi Lee; Sora Han; Myeong-Sok Lee; Jong-Seok Lim; Do Young Yoon; Yongil Kwon; Young Yang Journal: Cell Oncol (Dordr) Date: 2013-10-10 Impact factor: 6.730
Authors: Claudia A Nold-Petry; Ina Rudloff; Yvonne Baumer; Menotti Ruvo; Daniela Marasco; Paolo Botti; Laszlo Farkas; Steven X Cho; Jarod A Zepp; Tania Azam; Hannah Dinkel; Brent E Palmer; William A Boisvert; Carlyne D Cool; Laima Taraseviciene-Stewart; Bas Heinhuis; Leo A B Joosten; Charles A Dinarello; Norbert F Voelkel; Marcel F Nold Journal: J Immunol Date: 2013-12-11 Impact factor: 5.422
Authors: Cezmi A Akdis; Claus Bachert; Cemal Cingi; Mark S Dykewicz; Peter W Hellings; Robert M Naclerio; Robert P Schleimer; Dennis Ledford Journal: J Allergy Clin Immunol Date: 2013-04-12 Impact factor: 10.793
Authors: O Palomares; M Martín-Fontecha; R Lauener; C Traidl-Hoffmann; O Cavkaytar; M Akdis; C A Akdis Journal: Genes Immun Date: 2014-07-24 Impact factor: 2.676
Authors: Bonnie R Joubert; Janine F Felix; Paul Yousefi; Kelly M Bakulski; Allan C Just; Carrie Breton; Sarah E Reese; Christina A Markunas; Rebecca C Richmond; Cheng-Jian Xu; Leanne K Küpers; Sam S Oh; Cathrine Hoyo; Olena Gruzieva; Cilla Söderhäll; Lucas A Salas; Nour Baïz; Hongmei Zhang; Johanna Lepeule; Carlos Ruiz; Symen Ligthart; Tianyuan Wang; Jack A Taylor; Liesbeth Duijts; Gemma C Sharp; Soesma A Jankipersadsing; Roy M Nilsen; Ahmad Vaez; M Daniele Fallin; Donglei Hu; Augusto A Litonjua; Bernard F Fuemmeler; Karen Huen; Juha Kere; Inger Kull; Monica Cheng Munthe-Kaas; Ulrike Gehring; Mariona Bustamante; Marie José Saurel-Coubizolles; Bilal M Quraishi; Jie Ren; Jörg Tost; Juan R Gonzalez; Marjolein J Peters; Siri E Håberg; Zongli Xu; Joyce B van Meurs; Tom R Gaunt; Marjan Kerkhof; Eva Corpeleijn; Andrew P Feinberg; Celeste Eng; Andrea A Baccarelli; Sara E Benjamin Neelon; Asa Bradman; Simon Kebede Merid; Anna Bergström; Zdenko Herceg; Hector Hernandez-Vargas; Bert Brunekreef; Mariona Pinart; Barbara Heude; Susan Ewart; Jin Yao; Nathanaël Lemonnier; Oscar H Franco; Michael C Wu; Albert Hofman; Wendy McArdle; Pieter Van der Vlies; Fahimeh Falahi; Matthew W Gillman; Lisa F Barcellos; Ashish Kumar; Magnus Wickman; Stefano Guerra; Marie-Aline Charles; John Holloway; Charles Auffray; Henning W Tiemeier; George Davey Smith; Dirkje Postma; Marie-France Hivert; Brenda Eskenazi; Martine Vrijheid; Hasan Arshad; Josep M Antó; Abbas Dehghan; Wilfried Karmaus; Isabella Annesi-Maesano; Jordi Sunyer; Akram Ghantous; Göran Pershagen; Nina Holland; Susan K Murphy; Dawn L DeMeo; Esteban G Burchard; Christine Ladd-Acosta; Harold Snieder; Wenche Nystad; Gerard H Koppelman; Caroline L Relton; Vincent W V Jaddoe; Allen Wilcox; Erik Melén; Stephanie J London Journal: Am J Hum Genet Date: 2016-03-31 Impact factor: 11.043